Cargando…

An Intranasal OMV-Based Vaccine Induces High Mucosal and Systemic Protecting Immunity Against a SARS-CoV-2 Infection

The development of more effective, accessible, and easy to administer COVID-19 vaccines next to the currently marketed mRNA, viral vector, and whole inactivated virus vaccines is essential to curtailing the SARS-CoV-2 pandemic. A major concern is reduced vaccine-induced immune protection to emerging...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Ley, Peter A., Zariri, Afshin, van Riet, Elly, Oosterhoff, Dinja, Kruiswijk, Corine P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721663/ https://www.ncbi.nlm.nih.gov/pubmed/34987509 http://dx.doi.org/10.3389/fimmu.2021.781280

Ejemplares similares

Modulating endotoxin activity by combinatorial bioengineering of meningococcal lipopolysaccharide
por: Zariri, Afshin, et al.
Publicado: (2016)

Intranasal Delivery of Thermostable Subunit Vaccine for Cross-Reactive Mucosal and Systemic Antibody Responses Against SARS-CoV-2
por: Nguyen, Khue G., et al.
Publicado: (2022)

Dendritic Cell Plasticity in Tumor-Conditioned Skin: CD14(+) Cells at the Cross-Roads of Immune Activation and Suppression
por: van de Ven, Rieneke, et al.
Publicado: (2013)

Lipid A heterogeneity and its role in the host interactions with pathogenic and commensal bacteria
por: Saha, Sukumar, et al.
Publicado: (2022)

Intranasal immunization with outer membrane vesicle pertussis vaccine confers broad protection through mucosal IgA and Th17 responses
por: Raeven, René H. M., et al.
Publicado: (2020)

Potentiating Lung Mucosal Immunity Through Intranasal Vaccination
por: Nelson, Sean A., et al.
Publicado: (2021)

Intranasal Vaccination With Lipoproteins Confers Protection Against Pneumococcal Colonisation
por: Voß, Franziska, et al.
Publicado: (2018)

Mucosal Immunity and Protective Efficacy of Intranasal Inactivated Influenza Vaccine Is Improved by Chitosan Nanoparticle Delivery in Pigs
por: Dhakal, Santosh, et al.
Publicado: (2018)

Development of Cross-Protective Influenza A Vaccines Based on Cellular Responses
por: Soema, Peter Christiaan, et al.
Publicado: (2015)

An intranasal vaccine targeting the receptor binding domain of SARS-CoV-2 elicits a protective immune response
por: Chen, Li, et al.
Publicado: (2022)

Immunogenicity and pre-clinical efficacy of an OMV-based SARS-CoV-2 vaccine
por: Grandi, Alberto, et al.
Publicado: (2023)

Immunogenicity and Pre-Clinical Efficacy of an OMV-Based SARS-CoV-2 Vaccine
por: Grandi, Alberto, et al.
Publicado: (2023)

Caveolin-1 regulates OMV-induced macrophage pro-inflammatory activation and multiple Toll-like receptors
por: Sivanantham, Ayyanar, et al.
Publicado: (2023)

Exploitation of Neisseria meningitidis Group B OMV Vaccines Against N. gonorrhoeae to Inform the Development and Deployment of Effective Gonorrhea Vaccines
por: Petousis-Harris, Helen, et al.
Publicado: (2019)

In silico identification and modification of T cell epitopes in pertussis antigens associated with tolerance
por: Kruiswijk, Corine, et al.
Publicado: (2020)

A Thermostable Oral SARS-CoV-2 Vaccine Induces Mucosal and Protective Immunity
por: Bellier, Bertrand, et al.
Publicado: (2022)

Functionalization of OMVs for Biocatalytic Applications
por: Amalia, Lita, et al.
Publicado: (2023)

A nasal vaccine with inactivated whole-virion elicits protective mucosal immunity against SARS-CoV-2 in mice
por: Tokunoh, Nagisa, et al.
Publicado: (2023)

Experimental studies using OMV in a new platform of SARS-CoV-2 vaccines
por: Gaspar, Emanuelle B., et al.
Publicado: (2021)

Intranasal Immunization with Liposome-Displayed Receptor-Binding Domain Induces Mucosal Immunity and Protection against SARS-CoV-2
por: Huang, Wei-Chiao, et al.
Publicado: (2022)

The Bacterial Mucosal Immunotherapy MV130 Protects Against SARS-CoV-2 Infection and Improves COVID-19 Vaccines Immunogenicity
por: del Fresno, Carlos, et al.
Publicado: (2021)

Intranasal Delivery of MVA Vector Vaccine Induces Effective Pulmonary Immunity Against SARS-CoV-2 in Rodents
por: Bošnjak, Berislav, et al.
Publicado: (2021)

Evaluation of a protective effect of in ovo delivered Campylobacter jejuni OMVs
por: Godlewska, Renata, et al.
Publicado: (2016)

Single-dose intranasal vaccination elicits systemic and mucosal immunity against SARS-CoV-2
por: An, Xingyue, et al.
Publicado: (2021)

Protective Intranasal Immunization Against Influenza Virus in Infant Mice Is Dependent on IL-6
por: Bonney, Elizabeth Ann, et al.
Publicado: (2020)

Shortening the Lipid A Acyl Chains of Bordetella pertussis Enables Depletion of Lipopolysaccharide Endotoxic Activity
por: Arenas, Jesús, et al.
Publicado: (2020)

Differences in systemic and mucosal SARS-CoV-2 antibody prevalence in a prospective cohort of Dutch children
por: Keuning, Maya W., et al.
Publicado: (2022)

Safety and Efficacy of Combined Intramuscular/Intranasal RAZI-COV PARS Vaccine Candidate Against SARS-CoV-2: A Preclinical Study in Several Animal Models
por: Banihashemi, Seyed Reza, et al.
Publicado: (2022)

Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses
por: Mao, Tianyang, et al.
Publicado: (2022)

Intranasal Administration of RBD Nanoparticles Confers Induction of Mucosal and Systemic Immunity against SARS-CoV-2
por: Jearanaiwitayakul, Tuksin, et al.
Publicado: (2021)

Editorial: Mucosal immunity to HIV and SARS-CoV-2 infection and vaccination
por: Bomsel, Morgane, et al.
Publicado: (2023)

Egg-Derived Anti-SARS-CoV-2 Immunoglobulin Y (IgY) With Broad Variant Activity as Intranasal Prophylaxis Against COVID-19
por: Frumkin, Lyn R., et al.
Publicado: (2022)

Mucosal immunization with Ad5-based vaccines protects Syrian hamsters from challenge with omicron and delta variants of SARS-CoV-2
por: Braun, Molly R., et al.
Publicado: (2023)

Protection from COVID-19 disease in hamsters vaccinated with subunit SARS-CoV-2 S1 mucosal vaccines adjuvanted with different adjuvants
por: Sui, Yongjun, et al.
Publicado: (2023)

The Mucosal and Serological Immune Responses to the Novel Coronavirus (SARS-CoV-2) Vaccines
por: Chan, Renee W. Y., et al.
Publicado: (2021)

Mucosal immunity: The missing link in comprehending SARS-CoV-2 infection and transmission
por: Russell, Michael W., et al.
Publicado: (2022)

Intranasal administration of a single dose of MVA-based vaccine candidates against COVID-19 induced local and systemic immune responses and protects mice from a lethal SARS-CoV-2 infection
por: Pérez, Patricia, et al.
Publicado: (2022)

Intranasal Lentiviral Vector-Mediated Antibody Delivery Confers Reduction of SARS-CoV-2 Infection in Elderly and Immunocompromised Mice
por: Du, Yue, et al.
Publicado: (2022)

An intranasal vaccine durably protects against SARS-CoV-2 variants in mice
por: Hassan, Ahmed O., et al.
Publicado: (2021)

Heterologous Display of Chlamydia trachomatis PmpD Passenger at the Surface of Salmonella OMVs
por: Huynh, Dung T., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_npihu2lplm240pt8uq394tss8s